Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3928studies shown
Showing 3,151-3,175 of 3,928
CompletedNCT03658824

Behavioural Activation for Depression in bipolarity: A Case Series

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Exeter
Condition
Bipolarity
CompletedNCT04855409

Neuronal Integrity in Depression in bipolarity

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Global
Sponsor
Mehmet Diyaddin Güleken
Condition
Bipolarity
CompletedNCT03404882

Peer Support Experience for Patients Discharged From Acute Psychiatric Care

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University of Alberta
Condition
Schizophrenia
CompletedNCT00282464

A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression.

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
CompletedNCT00141271

A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
TerminatedNCT00055575

Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression
CompletedNCT01431573

Wake Therapy in the Treatment of Depression

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve sleep, daily rhythms, and longer-term stability.

DepressionOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Depression
CompletedNCT00483548

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Australia, India, United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
WithdrawnNCT03764683

Suvorexant (Belsomra) for the Treatment of Depression in bipolarity With Insomnia

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

BipolarityOtherFrom 18 Years to 75 Years
Countries
Global
Sponsor
Massachusetts General Hospital
Condition
Bipolarity
TerminatedNCT00400088

Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolarity or Suicide

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Depression
TerminatedNCT02882711

The UTHealth Ketamine Project

This study exists to explore whether ketamine treatment could improve care and understanding. Researchers are trying to understand whether ketamine treatment can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression
CompletedNCT02918097

Cost- Effectiveness and Quality of Life Assessment in Bipolarity Depressive Episode

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Global
Sponsor
Federal University of Rio Grande do Sul
Condition
Bipolarity
CompletedNCT03062267

Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

SchizophreniaOtherFrom 18 Years to 99 Years
Countries
United States
Sponsor
University of Washington
Condition
Schizophrenia
CompletedNCT00436020

rTMS in the Treatment of Depression in bipolarity

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 70 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Bipolarity
CompletedNCT00961961

Prevention of Relapse & Recurrence of Depression in bipolarity

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can better prevent setbacks and support longer-term stability.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Bipolarity
CompletedNCT03638687

Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Depression
CompletedNCT01869374

Study Comparing Magnetic Seizure Therapy (MST) to Electroconvulsive Therapy (ECT) for Depression in Older Adults

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 55 Years to 90 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Depression
CompletedNCT02765100

Depression, Obesity and Inflammatory Markers

This study exists to see whether blood tests and biological markers is workable and worth testing more broadly. Researchers are trying to understand what blood tests and biological markers could change in day-to-day care and decision-making.

DepressionOtherFrom 18 Years to 99 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Depression
TerminatedNCT01624831

Social Cognition in Longstanding Psychosis

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
University of Arizona
Condition
Schizophrenia
CompletedNCT01570972

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Arizona
Condition
Schizophrenia
CompletedNCT01196286

Multifamily Psychoeducation and Cognitive Remediation for Recent-Onset Psychosis

This study exists to explore whether psychoeducation, a guided learning and support program, could improve care and understanding. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Arizona
Condition
Schizophrenia